Tang Tengqian, Feng Xiaobin, Yan Jun, Xia Feng, Li Xiaowu, Ma Kuansheng, Bie Ping
Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University , Chongqing , China.
Int J Hyperthermia. 2014 Sep;30(6):402-7. doi: 10.3109/02656736.2014.951404.
Radiofrequency ablation (RFA) is a minimally invasive technique used for the treatment of hepatocellular carcinoma (HCC). It may produce complications. The indocyanine green (ICG) retention rate at 15 min (ICGR15) has been used to predict complications after hepatectomy. In this study, the prediction of the value of ICGR15 for complications of RFA to the patients with HCC was evaluated.
Some 878 cases of HCC treated between June 2009 and June 2013 were evaluated. All patients were treated by percutaneous radiofrequency ablation. Patients were divided into two groups: a complication group (85 cases) and a complication-free group (793 cases). ICGR15 and other baseline characteristics of the two groups were compared. A logistic regression model was used to analyse the merits of assessing liver reserve to predict complications post-RFA.
Complications such as intra-abdominal haemorrhage and pleural effusion occurred in 85 (9.68%) patients after RFA. Patients in the two groups did not differ with regard to baseline parameters. Patients in the two groups did differ significantly in ICGR15 and tumour site (p < 0.05). Tumour site was found to have a significant impact on the rate of complications post-RFA. There was no significant difference in ICGR15 values among patients with the same Child-Pugh scores or in the same tumour site.
The present results demonstrated that RFA is minimally invasive and suitable for the treatment of HCC. They also showed that ICGR15 did not independently predict for liklihood of post-RFA complications, after controlling for tumour site. Patients with tumours located subcapsularly or near the porta hepatis were found to have significantly higher rates of post-operative complications after RFA than to patients with tumours in the liver parenchyma.
射频消融术(RFA)是一种用于治疗肝细胞癌(HCC)的微创技术。它可能会产生并发症。15分钟吲哚菁绿(ICG)滞留率(ICGR15)已被用于预测肝切除术后的并发症。在本研究中,评估了ICGR15值对HCC患者RFA并发症的预测价值。
对2009年6月至2013年6月间治疗的878例HCC患者进行评估。所有患者均接受经皮射频消融治疗。患者分为两组:并发症组(85例)和无并发症组(793例)。比较两组的ICGR15及其他基线特征。采用逻辑回归模型分析评估肝脏储备以预测RFA术后并发症的优点。
RFA术后85例(9.68%)患者出现腹腔内出血、胸腔积液等并发症。两组患者的基线参数无差异。两组患者的ICGR15和肿瘤部位有显著差异(p<0.05)。发现肿瘤部位对RFA术后并发症发生率有显著影响。相同Child-Pugh评分或相同肿瘤部位的患者ICGR15值无显著差异。
目前结果表明,RFA具有微创性,适用于HCC的治疗。结果还表明,在控制肿瘤部位后,ICGR15不能独立预测RFA术后并发症的可能性。发现位于肝包膜下或肝门附近的肿瘤患者RFA术后的并发症发生率明显高于肝实质内肿瘤患者。